In case of damage to the cell membrane, H-FABP is rapidly released into circulation and therefore was evaluated for use in diagnosis and risk stratification of coronary artery disease and acute coronary syndrome [24,25]. This evidence concerns the gene FABP3 and acute coronary syndrome.